Supriya Peshin: It’s truly an honor to meet Naveen Pemmaraju
Supriya Peshin, Internal Medicine Resident at Ballad Health, shared a post on X:
“Yes, Dr. Pemmaraju, we are finally meeting in person after being long-time Twitter buddies – it’s truly an honor! Your brilliance and contributions have always been remarkable. Thank you for being so welcoming and looking forward to meet you soon at MD Anderson.
Van Morris your absence was certainly felt and you were greatly missed.”
More posts featuring Supriya Peshin.
Supriya Peshin is an Internal Medicine Resident at Ballad Health. She previously completed a visiting residency in Hematology and Oncology at the University of Arizona Health Sciences. She was also an Internal Medicine Resident at the East Tennessee State University James H. Quillen College of Medicine.
Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network.
He is also the Leukemia Hematology/Oncology Course Director. His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023